Volume 20, Issue 5 (8-2021)
JRUMS 2021, 20(5): 571-596 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Doost Mohammadi F, Rezaeian M. Epidemiology and Strategies for Coping with Novel Coronavirus Disease (COVID-19): A Narrative Review. JRUMS 2021; 20 (5) :571-596
URL: http://journal.rums.ac.ir/article-1-5541-en.html
URL: http://journal.rums.ac.ir/article-1-5541-en.html
Epidemiology and Strategies for Coping with Novel Coronavirus Disease (COVID-19): A Narrative Review
Full-Text [PDF 480 kb]
(2124 Downloads)
| Abstract (HTML) (4145 Views)
Full-Text: (5702 Views)
Epidemiology and Strategies for Coping with Novel Coronavirus Disease (COVID-19): A Narrative Review
F. Doost Mohammadi[1], A. Rahmani2, M. Rezaeian3
Received: 13/07/20 Sent for Revision: 10/12/20 Received Revised Manuscript: 10/05/21 Accepted: 19/05/21
On 21 December 2019, the Chinese government reported to the World Health Organization (WHO) a number of cases that looked like a common cold. On 6 January 2020, Chinese authorities reported sixty suspected cases, of which seven were very serious. On 9 January, the China Center for Disease Control and Prevention identified the virus genome sequence of the disease and made it available to the scientists worldwide. On 11 February, the disease was called novel coronavirus disease (COVID-19) by WHO, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Coronaviruses are a group of viruses that cause damage to various parts of the respiratory tract. Despite all efforts, at the time of this writing, the official number of cases was more than 209,876,613, and the number of victims exceeded 4,400,284 persons. to date, 4,562,256,778 doses of vaccine have been injected against this disease .The case fatality rate of Covid-19 has varied from 0.08% to 10.8% in the world, but fortunately the number of patients who have recovered is very promising and more than 66 million people have recovered. Considering the great importance of this disease and its increasing spread, the purpose of this article is to review the most important scientific evidence regarding the epidemiology of the disease and some strategies to cope with it.
Key words: Covid-19, Epidemiology, Control, Prevention
Funding: None declared.
Conflict of interest: None declared.
How to cite this article: Doost Mohammadi F, Rahmani A, Rezaeian M. Epidemiology and Strategies for Coping with Novel Coronavirus Disease (COVID-19): A Narrative Review. J Rafsanjan Univ Med Sci 2021; 20 (5): 571-96. [Farsi]
[1] - PhD Student in Epidemiology, Epidemiology and Biostatistics Dept., Yazd Public Health School, Yazd University of Medical Sciences, Yazd, Iran, ORCID: 0000-0003-3867-4214
2-MS Student of Epidemiology, Social Determinants in Health Promotion Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran, ORCID: 0000-0002-7218-8706
3-Prof., Dept. of Epidemiology and Biostatistics, Occupational Environmental Research Center, Medical School, Rafsanjan University of
Medical Sciences, Rafsanjan, Iran, ORCID: 0000-0003-3070-0166
(Corresponding Author) Tel: (034) 31315123, Fax: (034) 31315123, E-mail: moeygmr2@yahoo.co.uk
F. Doost Mohammadi[1], A. Rahmani2, M. Rezaeian3
Received: 13/07/20 Sent for Revision: 10/12/20 Received Revised Manuscript: 10/05/21 Accepted: 19/05/21
On 21 December 2019, the Chinese government reported to the World Health Organization (WHO) a number of cases that looked like a common cold. On 6 January 2020, Chinese authorities reported sixty suspected cases, of which seven were very serious. On 9 January, the China Center for Disease Control and Prevention identified the virus genome sequence of the disease and made it available to the scientists worldwide. On 11 February, the disease was called novel coronavirus disease (COVID-19) by WHO, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Coronaviruses are a group of viruses that cause damage to various parts of the respiratory tract. Despite all efforts, at the time of this writing, the official number of cases was more than 209,876,613, and the number of victims exceeded 4,400,284 persons. to date, 4,562,256,778 doses of vaccine have been injected against this disease .The case fatality rate of Covid-19 has varied from 0.08% to 10.8% in the world, but fortunately the number of patients who have recovered is very promising and more than 66 million people have recovered. Considering the great importance of this disease and its increasing spread, the purpose of this article is to review the most important scientific evidence regarding the epidemiology of the disease and some strategies to cope with it.
Key words: Covid-19, Epidemiology, Control, Prevention
Funding: None declared.
Conflict of interest: None declared.
How to cite this article: Doost Mohammadi F, Rahmani A, Rezaeian M. Epidemiology and Strategies for Coping with Novel Coronavirus Disease (COVID-19): A Narrative Review. J Rafsanjan Univ Med Sci 2021; 20 (5): 571-96. [Farsi]
2-MS Student of Epidemiology, Social Determinants in Health Promotion Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran, ORCID: 0000-0002-7218-8706
3-Prof., Dept. of Epidemiology and Biostatistics, Occupational Environmental Research Center, Medical School, Rafsanjan University of
Medical Sciences, Rafsanjan, Iran, ORCID: 0000-0003-3070-0166
(Corresponding Author) Tel: (034) 31315123, Fax: (034) 31315123, E-mail: moeygmr2@yahoo.co.uk
Type of Study: Review Article |
Subject:
Statistics& Epidemiology
Received: 2020/08/11 | Accepted: 2021/05/19 | Published: 2021/08/19
Received: 2020/08/11 | Accepted: 2021/05/19 | Published: 2021/08/19
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
